Today’s stock pick update – Open Now

Learn More You Could Make $300 to $1100 Per Contract With This Simple Trade Imagine getting really good at mastering just ONE simple trade. A trade that appears like clockwork between 9:30-10:45am on most trading days. This free step-by-step guide, by options expert, Dave Acquino, shows you how to spot and take these trades so you can walk away with daily profits!(Ad) CLICK HERE for instant access. Stocks Are Higher After Treasury Secretary Mnuchin Says He’s “Hopeful” Agreement Can Be Reached On New Stimulus Deal

Treasury Secretary Steven Mnuchin struck a “hopeful” tone on stimulus, Mnuchin said he will speak again with House Speaker Nancy Pelosi today regarding a possible deal, with an aim to reach “understanding” with Pelosi on a broad relief package by Thursday. “I say we’re going to give it one more serious try to get this done and I think we’re hopeful that we can get something done,” Mnuchin said. “I think there is a reasonable compromise here.” While House D... Read More

Sorrento Therapeutics (NASDAQ: SRNE): Sorrento Therapeutics gained 20% yesterday after the biotech released encouraging preclinical data for its experimental COVID-19 antibody therapies STI-1499 and STI-2020. “We believe that the results for STI-1499 and STI-2020 are truly remarkable. Based on the preclinical testing we have conducted to date, STI-2020 is our most promising SARS-... Read More

ACCO has a great value proposition – is the timing right for this stock? It is interesting to observe the disconnect between broad stock market expectations versus the economic data that points to a much more gradual pace of economic growth. One of the places where I think that can be seen more easily is in evaluating large-cap versus small-cap stocks. Many of the biggest and most recognizable names in the market have followed the broad indices higher, and if you look at the fundamentals of many of those companies, there are clear indications that they have been a... Read More

Featured Stock Sorrento Therapeutics, Inc. (SRNE) – Buy Price: $12.50 or better Sorrento Therapeutics, Inc., a clinical stage biopharma company, develops therapies for cancer, autoimmune, inflammatory, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutics by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugates, as well as b... Read More

Other Top Stories Assange bugged while at Ecuadorian Embassy, UK court told Caesars Entertainment buys bookmaker William Hill for $3.7B FAA chief will test changes to Boeing's grounded 737 Max World leaders, virtual meeting 1.0: Was anybody listening? Hot, dry conditions stoke devastating California wildfires

Trend Following Picks Sorrento Therapeutics, Inc. (SRNE) – Buy Price: $12.50 or better Veeva Systems Inc. (VEEV) – Buy Price: $287.00 or better Rafarma Pharmaceuticals, Inc. (RAFA) – Buy Price: $3.00 or better Nautilus, Inc. (NLS) – Buy Price: $17.00 or better Purple Innovation, Inc. (PRPL) – Buy Price: $25.00 or better All Picks

Reversal Picks Yiren Digital Ltd. (YRD) Buy Target $3.23 Sell Target $3.55 Contango Oil & Gas Company (MCF) Buy Target $1.57 Sell Target $1.87 eMagin Corporation (EMAN) Buy Target $1.41 Sell Target $1.59 DPW Holdings, Inc. (DPW) Buy Target $2.96 Sell Target $3.83 WPX Energy, Inc. (WPX) Buy Target $5.21 Sell Target $5.87 All Picks

Low Price Stock Picks Reed’s, Inc. (REED) Zomedica Pharmaceuticals Corp. (ZOM) Camber Energy, Inc. (CEI) Moleculin Biotech, Inc. (MBRX) Hermitage Offshore Services Ltd. (PSV) All Picks

Already subscribed to our premium service? Click here to Login. Not a TradersPro subscriber yet? Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits

This email was sent to its028@gmail.com  by TradersPro Investiv, LLC 265 N. Main | Ste. D #283 Kaysville | UT | 84037 Unsubscribe or Mange which emails you get from TradersPro   All trading carries significant risk. Please see our full risk disclaimer. Disclaimers, Terms & Conditions | Privacy Policy Copyright © 2020